Review of 239Pu and 226Ra effects in beagles.
A long term biological study has been completed that was designed to assess the predicted effects in humans of internally deposited 239Pu by comparison with 226Ra in beagles. Herein we summarize for the first time results of several previous reports about the effects of these two radionuclides in our beagles in an attempt to elucidate what has been learned since the beginning of the study in the early 1950's. Perhaps the most important finding was that bone surface-seeking plutonium is more toxic at equal mean skeletal radiation doses (<3 Gy for 239Pu, <20 Gy for 226Ra) than bone volume-seeking radium for the induction of skeletal malignancy by about a factor of 16 for a single intravenous injection of monomeric 239Pu. In addition, ancillary studies have shown that when plutonium transfers continuously onto bone surfaces from a depot of particulate 239Pu in phagocytic cells, its relative toxicity per Gy average skeletal dose is enhanced by about a factor of 2. Juvenile animals or dogs injected as mature adults were only about half as sensitive for equal mean skeletal doses as dogs injected as young adults. Male and female dogs were about equally sensitive to radiation of the skeleton by either radionuclide. Findings about radiation-induced fractures are summarized as well as data on the induction of soft-tissue malignancies by 239Pu or 226Ra. Natural survival was not affected at the lower dosage levels of either 226Ra or 239Pu as compared with control dogs given no radioactivity, but the survival of animals at higher levels was reduced. No additional life-shortening effects beyond those attributable to occurrence of radiation-induced malignancies or other radiation-induced effects were suggested by analysis of data for low dosage levels.
Lloyd
R D
RD
University of Utah, Department of Radiology, Salt Lake City 4108-1218, USA. ray.lloyd@hsc.utah.edu
Taylor
G N
GN
Miller
S C
SC
Bruenger
F W
FW
Jee
W S
WS
D000818:Animals; D001859:Bone Neoplasms; D001842:Bone and Bones / Q000528:radiation effects*; D004285:Dogs; D005260:Female; D050723:Fractures, Bone / Q000209:etiology; D008297:Male; D009381:Neoplasms, Radiation-Induced; D011005:Plutonium / Q000494:pharmacology*; D011832:Radiation Injuries / Q000150:complications; D011883:Radium / Q000494:pharmacology*; D017695:Soft Tissue Injuries
D011005:Plutonium; D011883:Radium